Company Comparison
Oryzon Genomics vs AI Therapeutics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Oryzon Genomics | AI Therapeutics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Barcelona, Spain | San Diego |
| Founded | 2000 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | Series A |
| Total Funding | $50M | $48M |
| Valuation | — | — |
What They Build
Oryzon Genomics
Spanish biopharmaceutical company developing epigenetic therapies for cancer and CNS diseases using histone deacetylase and lysine demethylase inhibitors.
AI Therapeutics
A San Diego biotech company using AI to accelerate drug discovery and development processes.
Key Investors
Oryzon Genomics
AI Therapeutics
No investors listed.
Sector Overlap
Both Oryzon Genomics and AI Therapeutics operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.